Table 2.
Study, year [ref], location | Study design | Study setting | Recruitment method | Recruited participants | LC stage when recruited |
---|---|---|---|---|---|
1. Brodsky, 2021 [53], USA | Case study with pre-post survey | Outpatient subspecialty clinic within a Healthcare System | Referral through medical doctors or self-referred. The program was extensively covered in TV and print media |
N = 12 pre-post, n = 2 Case study Gender: women Age: Mean 50 years; case study 50, 78 (mean 64) years Ethnicity: case study: White non-Hispanic |
Not collected |
2. Bogolepova et al., 2021 [51], Russia | Two arm clinical trial with pre-post assessment | NR | NR |
N = 100 Gender: 41 women, 59 men Age: range 22–71 (mean 50) years Ethnicity: NR |
Had acute COVID-19 infection 5.4 months earlier |
3. Tereshin et al., 2021 [52], Russia | Controlled trial | Secondary care | NR |
N = 45 (21 intervention and 24 control) Gender: 22 women, 23 men Age: Intervention group: mean 56 years Comparison group: mean 57 years Ethnicity: NR |
NR |
4. Fowler-Davis et al., 2021[54], UK | Qualitative and pre-post assessment | University setting in collaboration with a local GP collaborative group | Through a local community wellbeing group and social prescribing network |
N = 10 recruited; 8 completed Gender: 6 women, 2 men Age: range 38–73 years Ethnicity: white British (n = 4), others (n = 4) |
At least 12 weeks post-infection (range 4–14 months) |
5. Harenwall et al., 2021 [55], UK | Single arm pre-post assessment | Primary care | Self-registration to the programme (health, social and care staff, and outreach to key stakeholders of different sites, e.g., hospital, care home, police, council workers, teachers, local charity workers) |
N = 219 registered; 149 completed pre-course assessment; 76 completed post course assessment Age: Pre-course: mean 47 years; Post course: mean 49 years Gender: Pre-course assessment: 112 women, 16 men, 21 missing gender Post-course assessment: 53 women, 8 men, 15 missing gender Ethnicity: Pre-course: white British (67%), South Asian (13%), Asian British (4%), mixed heritage (3%), missing (13%). Post-course: White British (79%), South Asian (7%), Asian British (3%), mixed heritage (4%), undisclosed (7%) |
A mean of 5.99 months since acute COVID-19 infection (SD 3.89) |
6. Łuckoś et al., 2021 [56], Poland | Case study | NR | NR |
N = 1 Gender: woman Age: 48 years Ethnicity: NR |
Had acute COVID-19 infection six months earlier |
7. Compagno et al., 2022 [57], Italy | Single arm pre-post design | Hospital out-patient care | NR |
N = 30 Gender: 12 women, 18 men Age: mean 58 years Ethnicity: NR |
A mean of 3 (range 1–6) months since resolution of acute COVID-19 infection |
8. Esin et al., 2022 [50], Russia | Three arm clinical trial with pre-post assessment | Home or hospital setting | NR |
N = 92 Gender: NR Age: Group 1 (n = 40) mean 43 years Group 2 (n = 32) mean 45 years Group 3 (n = 20) mean 45 years Ethnicity: NR |
Had acute COVID-19 infection 12 weeks earlier |
9. Brough et al., 2022 [58], UK | Service evaluation with pre-post assessment | Community setting | Self-referral, advertised through social media, social prescribing network and word of mouth |
N = 25 Gender: 15 women, 7 men, 3 gender not disclosed Age: range 15–92 years Ethnicity: white British (n = 18), white Asian (n = 1), other white background (n = 2), Chinese (n = 1), undisclosed (n = 3) |
NR |
10. Wagner et al., 2022 [59], Austria | Case report | Hospital rehabilitation department | NR |
N = 1 Gender: woman Age: 55 years Ethnicity: NR |
Had acute COVID-19 infection 6.5 months earlier |
11. Garcia-Molina et al., 2022 [60], Spain | RCT | Secondary care | Eligible clinical participants were included without seeking their permission as the sample was derived from clinical practice (without altering the care protocols) |
N = 91 treatment group (and 32 control group) Gender: 55 women, 36 men in treatment group Age: mean 50 years in treatment group Ethnicity: Spanish, white |
At least 12 weeks post-acute COVID-19 |
12. Philip et al., 2022 [61], UK | Parallel-group, single-blind RCT | Secondary care | Referral from LC clinics |
N = 150 (74 intervention, 76 control) Gender: 121 women, 26 men Age: mean 49 years Ethnicity: Intervention (white 82%, black/ British black 1%, Asian/British Asian 5%, mixed/multiple 4%, other 5%, undisclosed 3% Control: white (82%), black/British black (9%), Asian/British Asian (4%), mixed/multiple (3%), other (1%), undisclosed (1%) |
A mean time of 320 days (around 10.5 months) since Acute COVID-19 infection |
13. Tobinick et al., 2022 [62], USA | Case study | Secondary care | Treatment performed as part of standard medical practice, as requested by patient |
N = 1 Gender: woman Age: 48 years Ethnicity: White, non-Latino |
Had acute COVID-19 infection 12 months earlier |
14. Wang et al., 2022 [63], USA | Case study | NR | NR |
N = 1 Gender: woman Age: 55–60 Ethnicity: NR |
Had acute COVID-19 infection over a year earlier |
15. Skilbeck, 2022 [64], UK | Case study | Primary care | NR |
N = 1 Gender: man Age: 36 years Ethnicity: Asian British |
Had acute COVID-19 infection 8 months earlier |
16. Orendáčová et al., 2022 [65], Czech Republic | Single arm pre-post pilot study | Described as both secondary and quaternary care setting | Through social media |
N = 10 Gender: 7 women, 3 men Age: range 19- 46 (median 21) years Ethnicity: All participants are from Czech Republic |
A median time of 12 months (range 3–19 months) since having acute COVID-19 infection |
17. Koliadenko et al., 2022 [66], Ukraine | Single arm pre-post-follow up evaluation | Remote medical consultative psychological and psychiatric help | Self-referred for treatment |
N = 129 Gender: 68 women, 61 men Age: 27.9% between 50–59 years Ethnicity: NR |
NR |
LC Long COVID, NR not reported, RCT Randomised Controlled Trial